Fny Investment Advisers, LLC Global Blood Therapeutics, Inc. Transaction History

Fny Investment Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 19, 2022	BUY	$32.4 - $68.18 $560,520 - $1.18 Million	17,300 New	17,300 $1.18 Million
Q3 2019 Oct 25, 2019	SELL	$45.35 - $57.91 $874,710 - $1.12 Million	-19,288 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$52.6 - $63.29 $1.01 Million - $1.22 Million	19,288 New	19,288 $1.01 Million
Q4 2018 Jan 22, 2019	SELL	$31.54 - $46.67 $157,700 - $233,350	-5,000 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$38.0 - $51.1 $33,098 - $44,508	871 Added 21.09%	5,000 $190,000
Q2 2018 Jul 18, 2018	BUY	$38.7 - $50.15 $159,792 - $207,069	4,129 New	4,129 $186,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.